A former King & Spalding LLP partner suing Reliance Standard Life Insurance Co. for ignoring medical evidence and violating federal law by cutting off his benefits after he suffered blood and lung complications stemming from a gene mutation told a New York federal judge Friday that a settlement has been reached.
The Kansas Court of Appeals on Friday affirmed a defense verdict in a suit accusing two surgeons of botching a man's hernia repair surgery, saying the patient's "lack of informed consent" claim was properly tossed by the trial judge.
The National Labor Relations Board urged a New Jersey federal judge Friday to hold nursing home operator Alaris Health in civil contempt and impose monetary penalties for its repeated failures to show it has followed a court order to provide information requested by a union representing its employees.
An Illinois federal judge has denied class certification in a suit accusing Health Care Service Corp. of failing to properly cover breastfeeding support and counseling services, ruling that the mothers didn't show the insurer applied a uniform policy to the benefit claims.
Two more Democratic lawmakers Friday joined a growing list of politicians calling to investigate U.S. Department of Defense spending, following reports that the department redirected most of a $1 billion CARES Act appropriation meant to respond to the COVID-19 pandemic to non-emergency contractors instead.
The D.C. Circuit ruled Friday that Alaska Native corporations can't share in $8 billion in tribal government funding to deal with the COVID-19 pandemic, overturning a D.C. federal judge's ruling that ANCs were eligible for the CARES Act money.
President Donald Trump's recent executive order directing an already-swamped Congress to end surprise medical billing by Dec. 31 struck many in the employee benefits community as little more than a symbolic gesture — one that spotlights a significant issue for employers and benefit plans but fails to guarantee a solution.
Former defensive lineman Darren Mickell urged the Eleventh Circuit Friday to overturn a lower court's ruling upholding the National Football League retirement plan's decision to deny him disability benefits, arguing the plan's board failed to consider any of the evidence he presented.
A Massachusetts law firm was sued by the commonwealth, accusing it of accepting more than $90,000 in kickbacks in exchange for referring clients to a mail-order pharmacy that dispensed thousands of opioid prescriptions.
The Minority Corporate Counsel Association announced Friday that American biotech company Genentech, which is part of the multinational Roche Group, is its 2020 Employer of Choice, citing the company's use of data to hold leaders accountable for meeting diversity and inclusion goals.
A Massachusetts federal judge on Friday tossed a proposed class action that alleged home care referral website Care.com and its executives led investors to believe it did background checks on care providers, ruling the company didn't say it would vet every caregiver on its website.
Premera Blue Cross has agreed to pay $6.85 million to settle a probe into whether it breached the Health Insurance Portability and Accountability Act in its handling of a 2015 data breach that affected nearly 11 million people, U.S. health officials said Friday.
Cerner Corporation has reached a monetary deal with former employees who claim the company mismanaged their 401(k) plan, the workers told a Missouri federal court.
The North Carolina Supreme Court on Friday reinstated a $6.5 million jury verdict against a hospital that was sued for negligently treating a patient's chest pain and failing to prevent his death, saying a lower appeals court erred by wiping out a $5.5 million pain-and-suffering damages award.
A medical science company said Hiscox Inc. breached its insurance contract by not defending it against a suit from Georgia's attorney general alleging the company made more than $6.4 million from its fraudulent stem cell injection products.
The U.S. Securities and Exchange Commission filed suit in California federal court Friday against a top executive of biotechnology company Arrayit Corp. who it says conned investors into believing the company had developed a COVID-19 test and misled them about the status of financial reports.
The Brown Law Firm PC emerged Thursday as lead counsel in a federal consolidated suit seeking damages from directors and officers in the name of nutrition company Tivity Health Inc., who are blamed for a steep stock slump tied to its $1.3 billion acquisition of Nutrisystem Inc. in 2019.
An Ohio medical marijuana cultivator has sued a state cannabis regulator for taking no action on its expansion application, saying the agency is "punting" on the issue despite a pronounced shortage of marijuana in the Buckeye State.
In this week's Taxation With Representation, United Wholesale Mortgage goes public in a $16 billion merger, biotechnology firm Illumina Inc. buys cancer detection company Grail for $8 billion, and Microsoft spends $7.5 billion for two video game companies.
A Florida federal judge has denied an insurer's bid to toss a suit by a gynecologist's office alleging it wrongfully denied coverage of losses stemming from the COVID-19 shutdown, making it the fourth federal court case to move past the dismissal stage.
A Maryland medical marijuana dispensary ignored serial sexual harassment by a former manager and failed to investigate complaints about his lewd comments and inappropriate touching for more than a year, the U.S Equal Employment Opportunity Commission said.
Two top officials at a Massachusetts soldiers' home were criminally charged Friday with negligence for their role in a COVID-19 outbreak that killed 76 veterans, in what Attorney General Maura Healey called the first criminal case in the country against nursing home operators related to the pandemic.
The U.S. Food and Drug Administration announced a final rule Thursday that would allow states, tribes, pharmacists and wholesalers to import certain prescription drugs from Canada, following through on an executive order signed by President Donald Trump in July.
President Donald Trump on Thursday delivered a seemingly toothless promise to shield Americans with preexisting conditions, issued an ultimatum on legislation to curb surprise medical billing and unexpectedly announced he's mailing tens of millions of $200 drug discount cards just before the election.
Cannabis company Terrapin is accusing competitor Harmony Foundation of bypassing New Jersey's vetting process to open a medical marijuana dispensary in Hoboken, asking a court to revoke Harmony's application or force the company to be evaluated.
The Arizona Supreme Court's recent decision to eliminate prohibitions on nonlawyer ownership of law firms may show that the organized bar's long-standing rhetoric that such rules are essential to protecting the legal profession's core values is overblown, say Anthony Sebok at Cardozo School of Law and Bradley Wendel at Cornell Law School.
President Donald Trump's executive order on international reference pricing for Medicare drugs is likely to either languish in Congress or die in court, but more modest drug pricing reform measures may be viable in the coming year, say attorneys at Ropes & Gray.
Companies engaged in commerce related to COVID-19 or that have received Paycheck Protection Program funding should familiarize themselves with a fraud statute, under which the U.S. Department of Justice has been successful in obtaining injunctions even before defendants are charged with a crime, say attorneys at V&E.
Attorneys at Fisher Phillips identify litigation trends in the three most common types of COVID-19 claims filed against employers to date, and discuss risk-reduction and defense strategies.
Best practices that can help litigators write convincing discovery motions include thinking about the audience, addressing a few key questions, and leaving out boilerplate from supporting briefs, says Tom Connally at Hogan Lovells.
Congress has multiple means to take the politics out of federal judicial nominations and restore the independence of the U.S. Supreme Court — three of which can be implemented without a constitutional amendment, says Franklin Amanat at DiCello Levitt.
The First Circuit’s recent decision in Doe v. Harvard Pilgrim Health Care — affirming denial of health insurance coverage based on the de novo review standard under the Employee Retirement Income Security Act — is dubious because it deviates markedly from civil procedure requirements and conflicts with U.S. Supreme Court jurisprudence, says Mark DeBofsky at DeBofsky Sherman.
For the last 20 years, at the insistence of both parties, U.S. Supreme Court nominations have been fierce ideological battles — which is bad for the country and bad for the public's perception of the legitimacy of the court, say Judge Eric Moyé, Judge Craig Smith and Winston & Strawn partner Tom Melsheimer.
President Donald Trump's new executive order addressing pricing for drugs covered by Medicare Parts B and D glosses over enormous difficulties in restructuring Medicare operations and is unlikely to lead to any imminent changes, say attorneys at Debevoise.
Recent enforcement actions by federal agencies against businesses making products intended to protect against COVID-19 highlight why companies must understand which regulators they are answerable to, and what standards they must follow when producing, advertising, labeling and selling their goods, say attorneys at Crowell & Moring.
The Delaware Chancery Court's recent decision to halt the Anthem-Cigna merger on antitrust grounds is most notable for not holding Cigna liable for breaching its obligation to support the transaction, and underscores the vulnerability of merger-of-equals transactions to post-signing issues, say attorneys at Fried Frank.
Current privilege logging practices to identify what information is being withheld from discovery often lead to costly disputes, so practitioners should adopt a system based on trust and good faith, similar to the presumptions embedded in the business judgment rule for corporate directors and officers, say Kevin Brady at Volkswagen and Charles Ragan and Ted Hiser at Redgrave.
A little-noticed memo recently issued by the Trump administration in response to the pandemic, directing federal agencies to provide greater due process to individuals and companies under regulatory investigation, represents a long-overdue sea change in the way justice is carried out in enforcement proceedings, say Joan Meyer and Norman Bloch at Thompson Hine.
Financially robust law firms are entering the recruiting market aggressively knowing that dislocations like the COVID-19 crisis present rare competitive opportunities, and firms that remain on the sidelines when it comes to strategic hiring will be especially vulnerable to having their best talent poached, says Brian Burlant at Major Lindsey.
Public and private entities should revisit their incident response plans to ensure compliance with and understand the differences among heightened data breach notification requirements that five states and Washington, D.C., added or amended this year, says Jane Petoskey at Polsinelli.